title: Analyses of recombinant activated factor VII treatments from clinical practice for rapid bleeding and acute pain control in haemophilia patients with inhibitors.
authors.affiliation: Institute of Hematology and Blood Transfusion, Prague, Czech Republic. peter.salaj@uhkt.cz
authors.forename: P
authors.initials: P
authors.lastname: Salaj
authors.forename: P
authors.initials: P
authors.lastname: Ovesna
authors.forename: M
authors.initials: M
authors.lastname: Penka
authors.forename: U
authors.initials: U
authors.lastname: Hedner
mesh_terms: D059787:Acute Pain / Q000188:drug therapy*; D000700:Analgesics / Q000627:therapeutic use*; D025861:Blood Coagulation Disorders, Inherited / Q000188:drug therapy*; D019774:Blood Coagulation Factor Inhibitors / Q000097:blood; D015942:Factor VIIa / Q000627:therapeutic use*; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D012042:Registries; D012189:Retrospective Studies
chemical_list: D000700:Analgesics; D019774:Blood Coagulation Factor Inhibitors; D011994:Recombinant Proteins; C103587:recombinant FVIIa; D015942:Factor VIIa